Nearly a million people have been given “emergency” inoculations of two experimental coronavirus vaccines, a Chinese pharmaceutical company has confirmed.
Their effectiveness is unknown as Sinopharm has yet to provide any clinical data from trials of the vaccines.
Since the summer, China has been allowing inoculations with the vaccines – which have not yet been approved for wider use – in emergency cases, such as employees and students travelling abroad or workers vulnerable to exposure, such as healthcare workers.
